Company intelligence / Profile preview

Aerwave Medical Technologies

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Completed first-in-human feasibility study in five patients evaluating ultrasound-based lung denervation for COPD and asthma. Study demonstrated procedural feasibility and efficiency, with the platform eliminating the need for fluoroscopic guidance, esophageal marker balloons, and multiple catheter exchanges. The technology delivers precise circumferential ablation in a single energy application.

Therapeutic areas: OncologyPulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Aerwave Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerwave Medical Technologies.

Explore the full profile